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Abstract
Background: Open discectomy is the standard surgical procedure in the treatment of patients
with long-lasting sciatica caused by lumbar disc herniation. Minimally invasive approaches such as
microendoscopic discectomy have gained attention in recent years. Reduced tissue trauma allows
early ambulation, short hospital stay and quick resumption of daily activities. A comparative cost-
effectiveness study has not been performed yet. We present the design of a randomised controlled
trial on cost-effectiveness of microendoscopic discectomy versus conventional open discectomy in
patients with lumbar disc herniation.
Methods/Design: Patients (age 18–70 years) presenting with sciatica due to lumbar disc
herniation lasting more than 6–8 weeks are included. Patients with disc herniation larger than 1/3
of the spinal canal diameter, or disc herniation less than 1/3 of the spinal canal diameter with
concomitant lateral recess stenosis or sequestration, are eliglible for participation. Randomisation
into microendoscopic discectomy or conventional unilateral transflaval discectomy will take place
in the operating room after induction of anesthesia. The length of skin incision is equal in both
groups. The primary outcome measure is the functional assessment of the patient, measured by the
Roland Disability Questionnaire for Sciatica, at 8 weeks and 1 year after surgery. We will also
evaluate several other outcome parameters, including perceived recovery, leg and back pain,
incidence of re-operations, complications, serum creatine kinase, quality of life, medical
consumption, absenteeism and costs. The study is a randomised prospective multi-institutional
trial, in which two surgical techniques are compared in a parallel group design. Patients and
research nurses are kept blinded of the allocated treatment during the follow-up period of 2 years.
Discussion: Currently, open discectomy is the golden standard in the surgical treatment of lumbar
disc herniation. Whether microendoscopic discectomy is more cost-effective than unilateral
transflaval discectomy has to be determined by this trial.
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Sciatica due to lumbar disc herniation refractory to con-
servative treatment is effectively treated by surgery. The
primary goal of surgery is retrieval of herniated disc frag-
ments and decompression of the nerve root. Since the first
report of lumbar disc surgery in 1934 by Mixter and Barr
[1], who performed a laminectomy with transdural disc
removal, various less invasive techniques have been devel-
opped. With the introduction of the microscope, Yasargil
and Caspar refined the original laminectomy into the
open microdiscectomy [2,3]. This technique has become
the most common procedure worldwide. In 1997 Foley
and Smith introduced the transmuscular approach of
microendoscopic discectomy (MED) with advanced
optics and instruments applicated in laparoscopic surgery
[4]. Later, the original endoscopic procedure was modi-
fied with the operative microscope which has led to the
development of the Microscopic Endoscopic Tubular
Retractor System (METRX). This technique is subject of
our protocol.
The concept of minimally invasive spine surgery is less tis-
sue damage, while achieving good clinical outcome com-
parable with conventional open surgery. Patients are
expected to have less back pain, shorter hospitalisation
and quicker resumption of daily activities. Moreover, the
cost-effectiveness is expected to be superior.
The Cochrane review of lumbar disc surgery has shown
considerable evidence on the effectiveness of discectomy
in patients in whom conservative management has failed
[5]. Three studies compared microdiscectomy versus
standard open discectomy [6-8]. Use of the microscope
lengthened the surgical procedure but there was no signif-
icant difference in clinical outcome. The expected earlier
return to work was not realised. This could be explaned by
the rather small difference in invasiveness between micro-
discectomy and the frequently performed unilateral trans-
flaval approach by using loupe magnification. Nowadays,
these two procedures are lumped together. A randomised
controlled trial (RCT) between microdiscectomy with
microscope versus microdiscectomy with loupe magnifi-
cation has not been performed.
The Cochrane review did not include trials concerning
MED. However, MED has proven it's safety and efficiency
in multiple studies [4,9-15]. Three of these studies have
compared MED with conventional open discectomy
[10,12,13], 1 was randomised [12]. There is a trend
towards faster recovery and less tissue damage in MED,
although due to limited number of patients and method-
ological flaws, no firm evidence based conclusions can yet
be drawn.
The rational of MED is a muscle-splitting approach by
using sequential dilators and insertion of a tubular retrac-
tor, instead of subperiostal muscle dissection in the con-
ventional open procedure. Iatrogenic devascularisation
and denervation of paraspinal muscles is regarded to be
one of the causes of poor clinical outcome and failed-
back-surgery syndrome [16]. Therefore, the muscle-split-
ting technique of MED is expected to result in less tissue
damage since subperiostal muscle dissection is prevented.
However, 1 study of 40 patients failed to show a signifi-
cant difference in post-operative contrast enhanced mag-
netic resonance imaging (MRI) with respect to paraspinal
muscle damage between MED and conventional open dis-
cectomy [11].
Another parameter to analyse post-surgery tissue damage
is serum creatine kinase (CK) as indicator of muscle
injury. CK increases after spinal surgery and reaches a
maximal value 1 day after surgery [17]. Nakagawa et al.
have compared CK values on day 1 after MED and con-
ventional open discectomy. They showed a significant dif-
ference in postoperative CK in favor of the MED [10].
Whether this is related to clinical outcome is not known.
Minimally invasive spine surgery has limitations as well.
One of the disadvantage of MED is potential nerve root
injury because of limited exposure. On the contrary, it is
shown that MED causes less intraoperative nerve root irri-
tation compared to conventional surgery [12].
Another issue related to limited exposure is recurrent disc
herniation. The recurrence rate after MED is not known
but it is expected to be higher than after conventional
open discectomy since less disc material is retrieved. How-
ever, a recent randomised trial has shown superiority of
sequesterectomy only, compared to conventional discec-
tomy with regard to recurrence rate [18]. Therefore, the
relationship between the extent of disc retrieval and recur-
rence rate is debated. In our study we will weight the total
amount of disc retrieval in both surgical techniques and
correlate this with disc recurrency.
Like other new minimally invasive techniques, MED has a
learning curve which is related to surgery time, complica-
tions, conversion to the open procedure, and recurrent
disc herniation. It is demonstrated that a surgeon should
perform at least 30 procedures in order to be skilled and
know the pitfalls [14]. Skill acquisition of MED is neces-
sary before clinical assessment of MED versus conven-
tional open discectomy can be started. Therefore, in our
trial we have selected surgeons with large experience in
MED.
Presently, the golden standard in surgical treatment of
lumbar disc herniation is the unilateral transflaval discec-Page 2 of 7
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The purpose of our study is to assess whether MED is more
(cost)-effective than conventional open discectomy. The
cost-effectiveness results will be a trade-off between a
quicker relief in leg pain in the MED group versus the
advantage of lower costs in the conventional group. More-
over, we will identify possible subgroups of patients who
will substantially benefit from one of the allocated surgi-
cal treatments. Since MED is hypothesised to have a par-
ticularly favorable short term effect, we will set 8 weeks
and 1 year as primary measure points.
Methods/Design
We designed an observer and patient blinded randomised
cost-effectiveness trial in the treatment of lumbar disc her-
niation in which two surgical techniques are compared in
a parallel group design. The primary outcome measure is
the Roland Disability Questionnaire for Sciatica. The fol-
low-up period will last 2 years. In order to collect enough
patients, a multi-center design is necessary. The study pro-
tocol was approved in all participating hospitals.
Our primary question is whether MED is more (cost)-
effective than open discectomy. The analysis will be
focused on the proportion of patients who are recovered
to a normal functional situation at the short and long
term. Moreover, we want to identify certain subgroups
who may benefit more of one of the allocated treatments.
Patients
All patients between 18 and 70 years with sciatica lasting
more than 6–8 weeks are eligible for this study. Imaging
studies (MRI) must confirm a herniated disc larger than 1/
3 of the spinal canal diameter (figure 1), or a smaller her-
niated disc with concomitant lateral recess stenosis or
sequestration. Additional inclusion and exclusion criteria
are listed in table 1. Patients with small herniated discs
less than 1/3 of the spinal canal diameter are eligible for
our parallel study of percutaneous laser discus decompres-
sion (PLDD) which compares PLDD with conventional
discectomy. This trial will be discussed seperately.
Patients are referred by a neurologist with MRI and con-
ventional imaging of the lumbar spine. During the first
visit to the neurosurgical outpatient clinic, the patient's
history and a standard neurological examination will be
documented. Conform our selection criteria, the neuro-
surgeon decides whether a patient is eligible for the MED
trial. The study will be explained to the patient and, in
case of a positive reaction, an appointment is made with
one of the research nurses. Because the patient needs
some time to consider participation, the first visit to the
research nurse is planned after at least 2 days. After
informed consent, the questionnaires, outcome measures
and baseline variables are recorded.
Randomisation procedure
Patients will be randomly allocated to either MED or con-
ventional discectomy. Randomisation will take place on
the operating room within 4 weeks after the first visit to
the research nurse. A randomisation list is prepared for
every participating hospital-nurse combination. Variable-
sized blocks of random numbers are formed to ensure
equal distribution of the randomisation treatments over
hospitals and research nurses. The data manager at the
Table 1: Selection criteria for trial eligibility.
Inclusion:
• Age 18–70 years
• Persistent radiculair pain lasting more than 6–8 weeks
• Operation indication
• Disc herniation confirmed MRI
❍ unilateral disc herniation larger than 1/3 of the spinal canal 
diameter or
❍ unilateral disc herniation less than 1/3 of the spinal canal 
diameter with concomittant lateral recess stenosis or 
sequestration
• Informed consent
Exclusion:
• Previous lumbar surgery on the same disc level
• Cauda equina syndrome
• Spondylolytic or degenerative spondylolisthesis
• Central spinal canal stenosis
• Pregnancy
• Severe somatic or psychiatric illness
• Planned (e)migration to another country in the year after 
inclusion
• Inadequate knowledge of Dutch language
The size of the herniated disc in relation to the spinal canal diamet r is m asu ed at disc levelFigure 1
The size of the herniated disc in relation to the spinal canal 
diameter is measured at disc level.Page 3 of 7
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selection and allocation of patients, will prepare coded,
sealed envelopes containing the treatment allocation. In
the operating room, after induction of anesthesia, the sur-
geon will open the envelope and the allocated treatment
is performed. Patients and research nurses are kept
blinded for the allocated treatment during the follow-up
period of 2 years.
Intervention
Patients will be randomised into conventional unilateral
transflaval discectomy (A) or MED (B). Depending on the
surgeon and patient's preference, surgery will be per-
formed under general or spinal anesthesia. The patients
will be positioned prone and the affected disc level is ver-
ified with fluoroscopy. The participating surgeons have
large experience in both techniques. A standardized Case
Record Form (CRF) will register the surgeon's findings
and this CRF, together with the randomisation envelope,
will be returned to the data center in a sealed envelope.
(A) Unilateral transflaval discectomy
A small midline incision (2–3 cm) will be made and the
paravertebral muscles will be discected unilaterally. Lam-
inotomy will be performed when necessary. In order to
decompress the nerve root, the herniated disc will be
removed as much as possible through a unilateral transfl-
aval approach. All retrieved disc material will be collected
and weighted afterwards. The wound will be closed in lay-
ers with a suction drain when necessary. Patients will be
operated with loupe magnification or microscope
depending on the surgeon's preference.
(B) Microendoscopic discectomy
The same size midline incision will be made, the skin will
be retracted laterally and the guidewire and sequential
dilators will be placed paraspinal under lateral fluoros-
copy control. The tubular retractor will be connected to a
flexible arm and fixed. Under microscopic view a unilat-
eral flavectomy and discectomy will be peformed. All
removed disc material will be collected. The wound will
be closed in layers with a suction drain when necessary.
Whenever MED will be converted to an open discectomy,
the patient will maintain in group B conform the 'intent
to treat'principle.
Surgery will take place within 4 weeks after inclusion on
the outpatient neurosurgical clinic. Hospital admission
will be 2–7 days (including the day of admission),
depending on the usual care of the participating hospital.
During the immediate post-operative period the patients
will be mobilised as soon as possible with the help of a
physiotherapist. Attempts will be made to discharge the
patient as soon as possible in both study groups. The phy-
sician who will discharge the patient is not aware of the
performed treatment. Patients and their guided physio-
therapists are stimulated to resume homeactivities and
work as soon as possible.
Baseline data
The baseline questionnaire assesses demographics, hob-
bies, sports, work status, smoking status, back pain his-
tory, family history of sciatica, co-morbidity, weight and
length. The patient's satisfaction at work will be registered.
The treatment preference of both patient and surgeon will
be assessed on a 5-point scale ranging from "strong pref-
erence for conventional open discectomy" to "strong pref-
erence for MED". Moreover, the expected recovery 8 weeks
after surgery of both patient and surgeon will be regis-
tered.
Outcome assessment
We will use the below described validated outcome
parameters which will be assessed by means of question-
naires. Follow-up examinations by the research nurse will
take place 4, 8, 26 and 52 weeks after randomisation.
Patients will be neurologically examined and question-
naires will be filled in (table 2). In between at 1, 2, 6, 12,
38, 78 and after 104 weeks the main questionnaire (pri-
mary outcome measures) will be filled in at home and
send to the data center. The outpatient control by the neu-
rosurgeon will be at 8 weeks and more if necessary.
We hypothesise a difference in (cost)-effectiveness
between MED and conventional discectomy in favor of
the MED on the short term, and comparable (cost)-effec-
tiveness after 6–12 months. Therefore the main question-
naire will be answered at 8 weeks and 1 year after surgery.
Primary outcome measure
Roland Disability Questionnaire for Sciatica (RDQ). This
illness-specific 23 item functional assessment question-
naire is frequently used for low back pain and sciatica [19-
22]. Scores range from 0 to 23, reflecting a simple
unweighted sum of items endorsed by the respondent.
Patients with high scores at baseline have a severe disa-
bling sciatica. To define recovery, a difference of at least 11
points from baseline has to be seen. This self report meas-
ure of physical disability due to back and leg pain has
established validity, reliability, and responsiveness to
change [23].
Secondary outcome measures
1) Perceived recovery
This is a 7-point Likert scale measuring the perceived
recovery, varying from 'complete recovery' to 'worse than
ever'. This outcome scale has been used in previous stud-
ies and is regarded valid and responsive to change [24].
Next to this global selfassessment, a job and hobby spe-
cific Likert will be scored. During the intake of the studyPage 4 of 7
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functional disabilities in daily life, which they can use in
their own evaluation overall and in separate items.
2) Visual Anolog Scale (VAS) of leg pain
This parameter will measure the experienced pain inten-
sity in the leg during the week before visiting the research
nurse. Pain will be assessed on a horizontal 100 mm scale
varying from 0 mm, 'no pain', to 100 mm, 'the worst pain
imaginable'. Patients do not see the results of earlier
assessments and will score the pain experienced at the
visit. Reliability, validity and responsiveness of VAS have
been shown [25].
3) VAS of back pain and combined leg and back pain
Since many patients with sciatica have back pain as well,
we will also measure the intensity of solitary back pain
and the combination of leg and back pain. There may be
a difference in back pain between the muscle-splitting
microendoscopic technique and the conventional mus-
cle-discecting technique.
4) McGill pain questionnaire
Several qualities of perceived pain will be measured using
the Dutch version of the McGill Questionnaire [26].
5) Short-form 36 (SF 36)
This is a generic health status questionnaire which can
easily be filled out at home. The questionnaire consists of
36 items on physical and social status of the patient sub-
divided in 8 domains; 1) physical functioning, 2) physical
restrictions, 3) emotional restrictions, 4) social function-
ing, 5) somatic pain, 6) general mental health, 7) vitality
and 8) general health perception. The questions are
scored on a scale of 0 (worst health) to 100 (ideal health).
This questionnaire has been used frequently and is vali-
dated in surgical studies on low back pathology [27-29].
6) Sciatica Frequency and Bothersome Index (SFBI)
This is a scale ranging from 0 to 6, which can assess the fre-
quency (0 = never to 6 = always) and bothersome (0 = not
at all to 6 = extreme bothersome) of back and leg pain.
The sum of the results of four symptom questions yields
both indexes, ranging from 0 to 24. The four questions
are: leg pain, numbness and/or tingling in leg, weakness
in leg or foot, and pain in back or leg while sitting [19,30].
7) Prolo scale
This scale measures the evaluation of the surgeon and
research nurse of the patient's functional and economic
status. It has been used in outcome studies of lumbar spi-
nal operations [31].
Other outcome measures
1) Costs
The direct medical costs of hospital admission and surgery
will be based on an integral cost-analysis in three regional
participating hospitals. From this institutional analysis,
the constant costs per admission and the variabel costs per
admission day will be estimated. Knowing the duration of
hospitalisation, the individual costs of all operated
patients can be estimated. Other medical costs (including
physiotherapy, visits to general practioners and medical
specialists, nursing care and medication) will be registered
in a diary. In the diary the patient will also register non-
medical costs (including time costs, travel expenses and
domestic help). The research nurse will go through the
diary with the patient on every follow-up moment
throughout the study period of 2 years. To estimate the
indirect costs, like productivity costs, patients will register
Table 2: Data collection and outcome measures.
Time in weeks x 0 1 2 4 6 8 12 26 38 52 78 104
Treatment preference v v v v
Expected recovery at 8 weeks v
Likert v v v v v v v v v v v v v
Neurological examination v v v v v
Prolo v v v v v
Severity of complaints (VAS) v v v v v v v v v v v v
McGill v v v
Functional status (Roland) v v v v v v v v v v v v v
Health status (SF 36) v v v v v v v
EuroQol v v v v v v v v v v v v
SFBI v v v v v
Costs (diary) v v v v v v
Surgery v
CK v
Complications v v v v vPage 5 of 7
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ter the patient's work situation, work efficiency and gross
income on follow-up moments. Absenteeism will be val-
ued to the friction-cost method.
2) Incidence of re-operations
In general, re-operation is considered as bad outcome and
therefore used as an outcome measure. The incidence of
re-operation in both groups will be measured.
3) Complications
A systematic assessment of complications (including
wound infection, deep venous thrombosis, urine tract
infection, hematoma, and progressive neurological defi-
cit) will be carried out by the surgeon and research nurse.
Moreover, surgeons will be asked for perioperative com-
plications like cerebrospinal fluid leakage, nerve root
damage, and exploration on the wrong disc level.
4) Serum creatine kinase (CK)
Creatine kinase is a known marker of muscle damage. The
post-operative serum level of CK has a maximal value on
day 1 after spinal surgery [17]. Therefore, we will deter-
mine the serum CK before surgery and 1 day after surgery
in both groups to assess a possible correlation between CK
and extent of surgery, i.e. transmuscular versus muscle dis-
cection. Whether CK is correlated with back pain and
recovery will also be determined.
Sample size
The sample size is calculated on the basis of the Roland
Disability Questionnaire for Sciatica. A difference in effect
between MED and open discectomy is assumed whenever
MED will obtain at least 20% difference in Roland score
at 8 weeks after randomisation. Conventional open dis-
cectomy is assumed to have at least 60% good result 8
weeks after surgery. This means that MED is proven to be
more effective than conventional surgery whenever 80%
or more of the patients have a good outcome 8 weeks after
surgery. The numbers used for this sample size are drawn
from the Maine Lumbar Spine Study 1 year and 5 year
results and were discussed in detail recently [19,21].
This trial attempts to enroll 300 patients with lumbar disc
herniations (150 patients in both treatment groups,
including 8% loss to follow-up) which is regarded suffi-
cient to detect a difference of 20% (α = 0,05 and a power
of 90%) in the primary outcome.
Statistical analysis
Baseline comparability will be analysed by descriptive sta-
tistics to determine whether randomisation was success-
ful. Whenever necessarry, adjustments for baseline
variables will be performed in the analysis. Differences in
outcome measures between both groups, together with
95% confidence intervals, will be calculated. Besides a dif-
ference in recovery between the two groups, analysis of a
difference in time to recovery will be carried out as well.
All data are analysed according the "intent-to-treat princi-
ple". In addition, an explorative subgroup analysis is con-
ducted to investigate whether the treatment effect varies
over specific subgroups of patients (table 3). Data will be
stored via the internet-based secure data management sys-
tem "ProMISe" of the department of Medical Statistics
and Bioinformatics. The analyses will be carried out using
appropriate statistical software (e.g. SPSS).
Discussion
In this article we introduce a design of a RCT on the (cost)-
effectiveness of MED versus conventional unilateral trans-
flaval surgery in the treatment of lumbar disc herniation.
This is the first randomised prospective trial comparing
these two surgical techniques. Moreover, the study is
unique in the way that patient and research nurse are
blinded for the allocated treatment. The objective of this
trial is to determine whether the minimally invasive surgi-
cal technique of MED is more (cost)-effective than con-
ventional unilateral transflaval surgery. The inclusion
period will run until the end of 2006 and follow-up meas-
urements will be completed in the end of 2008.
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